Category: Webinar

Building BRIDGES: Understanding our Position in Multi-Sector Communication

Course Objective

  • Consider our own assumptions about multi-sector communication, and about ourselves as communicators
  • Explore how our disciplines and workplaces tend to have their own terminology, jargon, or language, which can become invisible to us over time
  • Learn the importance of identifying our core, foundational values, as well as considering who and what might help us as we build the next bridge

Date: June 4, 2019

Dr. Anne Marie Liebel, EdD
President Health Communication Partners LLC

In this month’s Log-in2Learn webinar, participants learn from Dr. Anne Marie Liebel about the BRIDGES (bi-directional, resource-based, inquiry as stance, digital and multi-modal, global and local, equity-focused, social and situated) approach to multi-sector communication. In this first of a three-part webinar series, Dr. Liebel focuses on how the self both informs and is reflected by our communication choices. The lecture provides five concrete steps to help viewers identify own assumptions, professional positions and personal values that illuminate their current communication strengths and needs. Throughout the webinar, Dr. Liebel provides several personal and professional anecdotes that illustrate the importance of self-reflection in multi-sector communication.

Presenter: Anne Marie Liebel, EdD President Health Communication Partners LLC

Participants will learn how to:

  1. Consider their our own assumptions about multi-sector communication, and about ourselves as communicators
  2. Explore how our disciplines and workplaces tend to have their own terminology, jargon, or language, which can become invisible to us over time
  3. Learn the importance of identifying our core, foundational values, as well as considering who and what might help us as we build the next bridge
Systems Thinking for Public Health: An Introduction
Systems Thinking for Public Health An Introduction

Course Objective

  • Define a system
  • Explain why systems thinking is important for public health
  • Describe 3 tools for systems thinking

Date: May 7, 2019

Dr. Jacqueline Merrill, PhD, MPH, RN

In this month’s Log-in2Learn webinar, participants learn from Dr. Jacqueline Merrill about the value of systems thinking in addressing major, complex public health challenges. The lecture provides an overview on public health’s emerging responsibility to engage multiple stakeholders and community partners in improving social determinants of health, as well as how systems thinking can facilitate the creation of context-specific solutions between them. Dr. Merrill introduces the major constructs and describes basic decision-making tools used in systems thinking. At the end of the lecture, Dr. Merrill illustrates in-depth examples in applying systems thinking techniques in public health.

Participants will learn how to:

  1. Define a system
  2. Explain why systems thinking is important for public health
  3. Describe 3 tools for systems thinking
The Purpose of Pilot Studies in Modern Research

Course Objective

  • Describe the cons of estimating effect sizes from pilot studies.
  • Contrast the cons of using pilot studies for power computations with pros of using the clinically meaningful estimate.
  • Describe the purpose of pilot studies in modern research.

Date: January 8, 2019

Martina Pavlicova, PhD, MS
Associate Professor of Biostatistics
Columbia University Medical Center

In this webinar, participants learn from Dr. Martina Pavlicova about the benefits and limitations of pilot testing in clinical research. First, Dr. Pavlicova uses a case study to provide a comprehensive review on hypothesis testing, random sampling, and data stratification. Since effect size and sample size effect power, participants learn that pilot studies have limited statistical significance. Dr. Pavlicova explains how piloting is still essential to clinical research when determining feasibility, acceptability, safety, and tolerability of a study.

Prescription Drug Monitoring Programs and Drug Poisonings: What do we know? What do we need to know?
Pharmacists Looking at Medication

Course Objective

  • Define prescription drug monitoring programs (PDMP)
  • List the measurement issues that arise when studying PDMPs and their effect on prescription opioid and heroin poisoning rates
  • Describe the evidence surrounding the effects of PDMPs on rates of nonfatal and fatal prescription opioid and heroin poisoning

Date: December 4, 2018

Silvia Martins MD, PhD
Associate Professor of Epidemiology
Columbia University Mailman School of Public Health

Magdalena Cerda, DrPH
Associate Professor, Department of Population Health
New York University School of Medicine

David Fink, MPhil, MPH
PhD Candidate, Epidemiology Department
Columbia University Mailman School of Public Health

Participants learn from Dr. Silvia Martins, Dr. Magdalena Cerda and Dr. David Fink about the use of prescription drug monitoring programs (PDMPs) in the United States. First, Dr. David Fink provides an overview in current PDMP practices, explains the inconsistent evidence related to their success in reducing fatal and nonfatal prescription drug poisoning, and explores the unintended consequences of PDMP implementation such as increased heroin poisoning rates. Then, Dr. Cerda categorizes different PDMPs as proactive and reactive, then describes their research of PDMP implementation from 1999 to 2016. Lastly, Dr. Martins explains how proactive PDMPs–which proactively provide unsolicited information to PDMP users, provide open access to law enforcement, and require frequent data reporting–are less likely to be associated with increased in fatal heroin poisonings than reactive PDMPs.

Activism and Health Promotion: A Primer
Black Lives Matter Protest

Course Objective

  • Describe influential frameworks for understanding activist successes and failures
  • Discuss contemporary social movements and their relevance to health promotion and public health
  • Describe common strategic challenges that face health activists

Date: October 2, 2018

Merlin Chowkwanyun, PhD, MPH
Donald Gemson Assistant Professor of Sociomedical Sciences
Columbia University Mailman School of Public Health

In October 2018’s Log-in2Learn webinar, participants learn from Dr. Merlin Chowkwanyun about the history and role of social movements in driving public health and health promotion efforts in the United States. The lecture addresses the considerations made by activists in health advocacy work, such as: opportunities for conciliation, confrontation, or compromise; rhetoric and framing of messages; audience sensitivity in social movements; positionality of activist groups; and the use of coalitions. Dr. Chowkwanyun applies these frameworks to describe and evaluate the strategies of past health topics associated with activist efforts, including: healthcare access, mass incarceration, HIV/AIDS, breast cancer, environmental justice, and vaccination. At the end of the lecture, Dr. Chowkwanyun describes three recent movements – Occupy Wall Street, Black Lives Matter, and Me Too – and forecasts their role in health policy development.

E-Cigarettes and Evolving Challenges for Tobacco Control
Woman Smoking E-Cigarette

Course Objective

  • Describe potential health risks posed by electronic cigarettes
  • Evaluate the effectiveness of e-cigarettes for smoking cessation
  • Describe the health risks posed by hookah smoking

Date: September 27, 2018

Kevin R. J. Schroth, JD, BA
Associate Professor
School of Public Health, Rutgers University

This webinar will describe how the market for tobacco products has grown more diverse. It will focus on the emergence of e-cigarettes, addressing trends in use, marketing, effectiveness for quitting, potential health impact, and government regulations. It will also address issues related to hookah smoking.

Change Management and You: How Change Impacts Public Health Professionals
Large Yellow Arrow

Course Objective

  • Name key competencies for managing change within public health
  • Identify and analyze situations where change affected initiatives in public health
  • Explain critical roles of the public health professional that serves as a “change agent”

Date: September 4, 2018

Emil J Sadloch, MA
Sadloch Development Associates

The Region 2 Public Health Training Center presents its monthly Log-in2Learn series. Starting September 2018, the series began its new focus on the de Beaumont Foundation Strategic Skill Areas, eight skills and knowledge areas needed to address complex public health problems. In this webinar, participants will learn from Mr. Emil J Sadloch about introductory concepts of change management, such as the definition of change management, types of change an organization might experience, and the cycle of change. Mr. Sadloch continues his presentation by give examples of how change agents can anticipate the effects of change with explanations of people’s personal change styles, signs of resistance, essential components of change management, and tools and key questions supervisors can use to manage change.

The Power and Promise of Treatment as Prevention and the U=U Campaign
Blue Pills

Course Objective

  • Describe the challenges in working with clients to understand the tenets of U=U
  • Describe how U=U can be combined with other biomedical technologies to help curtail HIV infection
  • Describe how HIV biomedical technologies function to counter the stigma associated with HIV
  • List the barriers associated with the uptake of HIV biomedical technologies
  • Describe how U=U can be leveraged to counter outdated HIV laws and policies
  • Describe the role patients have in advancing U=U messages with their providers.

Date: August 7, 2018

Perry N. Halkitis, PhD, MS, MPH
Dean & Professor, Rutgers School of Public Health
Professor, Rutgers RWJ Medical School; Graduate School of Applied and Professional Psychology; School of Public Affairs and Administration
Director, Center for Health, Identity, Behavior & Prevention Studies (CHIBPS)

In this webinar, Dr. Perry Halkitis presents on the concept of HIV treatment as prevention. First, Dr. Halkitis provides participants with an overview of pre- and post-exposure prophylaxis (PrEP and PEP) as well as treatment as prevention (TasP). He then discusses scientific evidence for TasP and its ability to reduce HIV transmission. Lastly, Dr. Halkitis describes the current interventions and programs to increase the number of people with an undetectable viral load and the future of HIV prevention by addressing biological, psychological, and social factors simultaneously.

Public Media Data for Public Health
Illustration of Graphs

Course Objective

  • Describe public media data available for disease surveillance
  • Describe public media data available for audience segmentation
  • Describe public media data available for message design and tailoring

Date: July 10, 2018

Dr. Joe Smyser, PhD
Public Good Projects

This webinar explores new ways to use public media data to solve large, complex public heatlh issues like opioid abuse and mental health. Dr. Joe Smyser explains how the Public Good Projects uses data from Facebook, Google, and designated market areas (DMAs) to create insights about a population’s health knowledge, attitudes, and beliefs in real time to inform public health media campaigns. Participants of this webinar will be exposed to case studies of how this data was used to create tailored messages for specific populations about opioids and mental health using digital marketing principles.

Health Disparities in HIV: Supporting Adolescents through the HIV Care Continuum
Hands Hold Red Ribbon

Course Objective

  • Define the adolescent specific HIV-related health disparities in the United States.
  • Describe the individual and structural level factors impeding youth’s progress through the HIV Care Continuum.
  • Identify potential individual and structural level intervention points to support the health of youth living with HIV.

Date: June 5, 2018

Dr. Amanda Tanner
Associate Professor
University of North Carolina Greensboro

This webinar explores the specific challenges associated with ensuring adolescents are able to access HIV screening and treatment. Dr. Amanda Tanner provides background on adolescent’s biological, cognitive, social, and legal changes as they progress to adulthood as well as the disparities of HIV diagnosis and care among adolescents, especially minority youth. This presentation continues with an overview of two studies that investigate care linkage and engagement for youth with newly diagnosed HIV as well as the HIV-related healthcare transition at adolescent clinics. Dr. Tanner provides recommendations for future interventions that will help adolescents know their HIV status, become linked with appropriate care, and maintain viral suppression

Region 2 Public Health Training Center